Lachesis is a clinical-stage biotech company dedicated to using its patented nasal spray technology to advance the treatment of diseases of the brain.
Using informed selection of drug candidates in our nasal spray technology we have shown good potential to deliver more drug to the brain with fewer medication side effects in order to provide greater benefits to patients.
Using informed selection of drug candidates in our nasal spray technology we have shown good potential to deliver more drug to the brain with fewer medication side effects in order to provide greater benefits to patients.